Caris Life Sciences Inc. (NASDAQ : CAI ) News

Caris Life Sciences Inc. (NASDAQ: CAI) News Releases

CAI News Releases

April 15, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients

April 13, 2026 08:30:27 am

SeekingAlpha

Caris Life Sciences: Post-IPO Pullback Creates A Long-Term Buy Opportunity

April 08, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients

April 02, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies

April 01, 2026 10:14:42 am

Zolmax

Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Average Rating of "Hold" from Analysts

March 31, 2026 06:00:00 pm

PR Newswire

Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect

March 26, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer

March 25, 2026 08:30:00 am

PR Newswire

Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026

March 24, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month

March 20, 2026 08:30:00 am

PR Newswire

Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account